|
1
|
Enzinger PC and Mayer RJ: Esophageal
cancer. N Engl J Med. 349:2241–2252. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Schuchert MJ, Luketich JD and Landreneau
RJ: Management of esophageal cancer. Curr Probl Surg. 47:845–946.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Fareed KR, Kaye P, Soomro IN, Ilyas M,
Martin S, Parsons SL and Madhusudan S: Biomarkers of response to
therapy in oesophago-gastric cancer. Gut. 58:127–143. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Gillies RS, Middleton MR and Blesing C: A
reply to evidence-based radiation oncology: Oesophagus. Radiother
Oncol. 94:387–388. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Berger B and Belka C: Evidence-based
radiation oncology: Oesophagus. Radiother Oncol. 92:276–290. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Borghesi S, Hawkins MA and Tait D:
Oesophagectomy after definitive chemoradiation in patients with
locally advanced oesophageal cancer. Clin Oncol (R Coll Radiol).
20:221–226. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Li N, Huang D, Lu N and Luo L: Role of the
LKB1/AMPK pathway in tumor invasion and metastasis of cancer cells
(Review). Oncol Rep. 34:2821–2826. 2015.PubMed/NCBI
|
|
8
|
Gan RY and Li HB: Recent progress on liver
kinase B1 (LKB1): Expression, regulation, downstream signaling and
cancer suppressive function. Int J Mol Sci. 15:16698–16718. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Zhou W, Zhang J and Marcus AI: LKB1 Tumor
suppressor: Therapeutic opportunities knock when LKB1 is
inactivated. Genes Dis. 1:64–74. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Momcilovic M and Shackelford DB: Targeting
LKB1 in cancer-exposing and exploiting vulnerabilities. Br J
Cancer. 113:574–584. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Herter-Sprie GS, Korideck H, Christensen
CL, Herter JM, Rhee K, Berbeco RI, Bennett DG, Akbay EA, Kozono D,
Mak RH, et al: Image-guided radiotherapy platform using single
nodule conditional lung cancer mouse models. Nat Commun.
5:58702014. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Saigusa S, Inoue Y, Tanaka K, Toiyama Y,
Kawamura M, Okugawa Y, Okigami M, Hiro J, Uchida K, Mohri Y and
Kusunoki M: Significant correlation between LKB1 and LGR5 gene
expression and the association with poor recurrence-free survival
in rectal cancer after preoperative chemoradiotherapy. J Cancer Res
Clin Oncol. 139:131–138. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Chen Z, Cheng K, Walton Z, Wang Y, Ebi H,
Shimamura T, Liu Y, Tupper T, Ouyang J, Li J, et al: A murine lung
cancer co-clinical trial identifies genetic modifiers of
therapeutic response. Nature. 483:613–617. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Xia C, Ye F, Hu X, Li Z, Jiang B, Fu Y,
Cheng X, Shao Z and Zhuang Z: Liver kinase B1 enhances
chemoresistance to gemcitabine in breast cancer MDA-MB-231 cells.
Oncol Lett. 8:2086–2092. 2014.PubMed/NCBI
|
|
15
|
Wang YQ, Dai WM, Chu XY, Yang B, Zhao M
and Sun Y: Downregulation of LKB1 suppresses Stat3 activity to
promote the proliferation of esophageal carcinoma cells. Mol Med
Rep. 9:2400–2404. 2014.PubMed/NCBI
|
|
16
|
Piao LS, Hur W, Kim TK, Hong SW, Kim SW,
Choi JE, Sung PS, Song MJ, Lee BC, Hwang D and Yoon SK:
CD133+ liver cancer stem cells modulate radioresistance
in human hepatocellular carcinoma. Cancer Lett. 315:129–137. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Paglin S, Hollister T, Delohery T, Hackett
N, McMahill M, Sphicas E, Domingo D and Yahalom J: A novel response
of cancer cells to radiation involves autophagy and formation of
acidic vesicles. Cancer Res. 61:439–444. 2001.PubMed/NCBI
|
|
18
|
Gewirtz DA, Hilliker ML and Wilson EN:
Promotion of autophagy as a mechanism for radiation sensitization
of breast tumor cells. Radiother Oncol. 92:323–328. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Zois CE and Koukourakis MI:
Radiation-induced autophagy in normal and cancer cells: Towards
novel cytoprotection and radio-sensitization policies? Autophagy.
5:442–450. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Moretti L, Cha YI, Niermann KJ and Lu B:
Switch between apoptosis and autophagy: Radiation-induced
endoplasmic reticulum stress? Cell Cycle. 6:793–798. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Raja E, Tzavlaki K, Vuilleumier R, Edlund
K, Kahata K, Zieba A, Morén A, Watanabe Y, Voytyuk I, Botling J, et
al: The protein kinase LKB1 negatively regulates bone morphogenetic
protein receptor signaling. Oncotarget. 7:1120–1143. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Just PA, Poncy A, Charawi S, Dahmani R,
Traore M, Dumontet T, Drouet V, Dumont F, Gilgenkrantz H, Colnot S,
et al: LKB1 and notch pathways interact and control biliary
morphogenesis. PLoS One. 10:e01454002015. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Wang J, Zhang K, Wang J, Wu X, Liu X, Li
B, Zhu Y, Yu Y, Cheng Q, Hu Z, et al: Underexpression of LKB1 tumor
suppressor is associated with enhanced Wnt signaling and malignant
characteristics of human intrahepatic cholangiocarcinoma.
Oncotarget. 6:18905–18920. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Lipovka Y and Konhilas JP: AMP-activated
protein kinase signalling in cancer and cardiac hypertrophy.
Cardiovasc Pharm Open Access. 4:pii: 1542015.
|
|
25
|
Dasgupta B and Chhipa RR: Evolving lessons
on the complex role of AMPK in normal physiology and cancer. Trends
Pharmacol Sci. 37:192–206. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Sanli T, Rashid A, Liu C, Harding S,
Bristow RG, Cutz JC, Singh G, Wright J and Tsakiridis T: Ionizing
radiation activates AMP-activated kinase (AMPK): A target for
radiosensitization of human cancer cells. Int J Radiat Oncol Biol
Phys. 78:221–229. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Storozhuk Y, Hopmans SN, Sanli T, Barron
C, Tsiani E, Cutz JC, Pond G, Wright J, Singh G and Tsakiridis T:
Metformin inhibits growth and enhances radiation response of
non-small cell lung cancer (NSCLC) through ATM and AMPK. Br J
Cancer. 108:2021–2032. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Muaddi H, Chowdhury S, Vellanki R, Zamiara
P and Koritzinsky M: Contributions of AMPK and p53 dependent
signaling to radiation response in the presence of metformin.
Radiother Oncol. 108:446–450. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Fasih A, Elbaz HA, Hüttemann M, Konski AA
and Zielske SP: Radiosensitization of pancreatic cancer cells by
metformin through the AMPK pathway. Radiat Res. 182:50–59. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Shaw RJ, Kosmatka M, Bardeesy N, Hurley
RL, Witters LA, DePinho RA and Cantley LC: The tumor suppressor
LKB1 kinase directly activates AMP-activated kinase and regulates
apoptosis in response to energy stress. Proc Natl Acad Sci USA.
101:3329–3335. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Hardie DG and Hawley SA: AMP-activated
protein kinase: The energy charge hypothesis revisited. Bioessays.
23:1112–1119. 2001. View Article : Google Scholar : PubMed/NCBI
|
